• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过综合生物信息学分别鉴定参与阿霉素诱导的急性和慢性心脏毒性的新型生物标志物。

Identification of novel biomarkers involved in doxorubicin-induced acute and chronic cardiotoxicity, respectively, by integrated bioinformatics.

作者信息

Qian Hongyan, Qian Yi, Liu Yi, Cao Jiaxin, Wang Yuhang, Yang Aihua, Zhao Wenjing, Lu Yingnan, Liu Huanxin, Zhu Weizhong

机构信息

Department of Pharmacology, School of Medicine and School of Pharmacy Nantong University, Nantong, China.

Cancer Research Center Nantong, Nantong Tumor Hospital and Tumor Hospital Affiliated to Nantong University, Nantong, China.

出版信息

Front Cardiovasc Med. 2023 Jan 11;9:996809. doi: 10.3389/fcvm.2022.996809. eCollection 2022.

DOI:10.3389/fcvm.2022.996809
PMID:36712272
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9874088/
Abstract

BACKGROUND

The mechanisms of doxorubicin (DOX) cardiotoxicity were complex and controversial, with various contradictions between experimental and clinical data. Understanding the differences in the molecular mechanism between DOX-induced acute and chronic cardiotoxicity may be an ideal entry point to solve this dilemma.

METHODS

Mice were injected intraperitoneally with DOX [(20 mg/kg, once) or (5 mg/kg/week, three times)] to construct acute and chronic cardiotoxicity models, respectively. Survival record and ultrasound monitored the cardiac function. The corresponding left ventricular (LV) myocardium tissues were analyzed by RNA-seq to identify differentially expressed genes (DEGs). Gene Ontology (GO), Kyoto Encyclopedia of Gene and Genome (KEGG), and Gene Set Enrichment Analysis (GSEA) found the key biological processes and signaling pathways. DOX cardiotoxicity datasets from the Gene expression omnibus (GEO) database were combined with RNA-seq to identify the common genes. Cytoscape analyzed the hub genes, which were validated by quantitative real-time PCR. ImmuCo and ImmGen databases analyzed the correlations between hub genes and immunity-relative markers in immune cells. Cibersort analyzed the immune infiltration and correlations between the hub genes and the immune cells. Logistic regression, receiver operator characteristic curve, and artificial neural network analysis evaluated the diagnosis ability of hub genes for clinical data in the GEO dataset.

RESULTS

The survival curves and ultrasound monitoring demonstrated that cardiotoxicity models were constructed successfully. In the acute model, 788 DEGs were enriched in the activated metabolism and the suppressed immunity-associated signaling pathways. Three hub genes (Alas1, Atp5g1, and Ptgds) were upregulated and were negatively correlated with a colony of immune-activating cells. However, in the chronic model, 281 DEGs showed that G protein-coupled receptor (GPCR)-related signaling pathways were the critical events. Three hub genes (Hsph1, Abcb1a, and Vegfa) were increased in the chronic model. Furthermore, Hsph1 combined with Vegfa was positively correlated with dilated cardiomyopathy (DCM)-induced heart failure (HF) and had high accuracy in the diagnosis of DCM-induced HF (AUC = 0.898, = 0.000).

CONCLUSION

Alas1, Atp5g1, and Ptgds were ideal biomarkers in DOX acute cardiotoxicity. However, Hsph1 and Vegfa were potential biomarkers in the myocardium in the chronic model. Our research, first, provided bioinformatics and clinical evidence for the discovery of the differences in mechanism and potential biomarkers of DOX-induced acute and chronic cardiotoxicity to find a therapeutic strategy precisely.

摘要

背景

阿霉素(DOX)心脏毒性的机制复杂且存在争议,实验数据和临床数据之间存在各种矛盾。了解DOX诱导的急性和慢性心脏毒性分子机制的差异可能是解决这一困境的理想切入点。

方法

分别给小鼠腹腔注射DOX(20mg/kg,一次)或(5mg/kg/周,三次)以构建急性和慢性心脏毒性模型。生存记录和超声监测心脏功能。通过RNA测序分析相应的左心室(LV)心肌组织以鉴定差异表达基因(DEG)。基因本体论(GO)、京都基因与基因组百科全书(KEGG)和基因集富集分析(GSEA)发现关键生物学过程和信号通路。将来自基因表达综合数据库(GEO)的DOX心脏毒性数据集与RNA测序相结合以鉴定共同基因。Cytoscape分析枢纽基因,并通过定量实时PCR进行验证。ImmuCo和ImmGen数据库分析枢纽基因与免疫细胞中免疫相关标志物之间的相关性。Cibersort分析免疫浸润以及枢纽基因与免疫细胞之间的相关性。逻辑回归、受试者工作特征曲线和人工神经网络分析评估枢纽基因对GEO数据集中临床数据的诊断能力。

结果

生存曲线和超声监测表明成功构建了心脏毒性模型。在急性模型中,788个DEG富集于激活的代谢和抑制的免疫相关信号通路。三个枢纽基因(Alas1、Atp5g1和Ptgds)上调,且与免疫激活细胞集落呈负相关。然而,在慢性模型中,281个DEG表明G蛋白偶联受体(GPCR)相关信号通路是关键事件。慢性模型中有三个枢纽基因(Hsph1、Abcb1a和Vegfa)增加。此外,Hsph1与Vegfa结合与扩张型心肌病(DCM)诱导的心力衰竭(HF)呈正相关,并且在诊断DCM诱导的HF方面具有较高准确性(AUC = 0.898,P = 0.000)。

结论

Alas1、Atp5g1和Ptgds是DOX急性心脏毒性的理想生物标志物。然而,Hsph1和Vegfa是慢性模型中心肌的潜在生物标志物。我们的研究首先为发现DOX诱导的急性和慢性心脏毒性机制差异及潜在生物标志物提供了生物信息学和临床证据,以精确找到治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a8e/9874088/811c7660d556/fcvm-09-996809-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a8e/9874088/aa6b8ee0be43/fcvm-09-996809-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a8e/9874088/b8632171b415/fcvm-09-996809-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a8e/9874088/5fb954e8c148/fcvm-09-996809-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a8e/9874088/17b227b497f6/fcvm-09-996809-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a8e/9874088/b6c9871ad773/fcvm-09-996809-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a8e/9874088/c983f5dd9680/fcvm-09-996809-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a8e/9874088/478ac13862a2/fcvm-09-996809-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a8e/9874088/899d7149687b/fcvm-09-996809-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a8e/9874088/0d0df8a887cc/fcvm-09-996809-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a8e/9874088/82a8af9cb2b7/fcvm-09-996809-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a8e/9874088/811c7660d556/fcvm-09-996809-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a8e/9874088/aa6b8ee0be43/fcvm-09-996809-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a8e/9874088/b8632171b415/fcvm-09-996809-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a8e/9874088/5fb954e8c148/fcvm-09-996809-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a8e/9874088/17b227b497f6/fcvm-09-996809-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a8e/9874088/b6c9871ad773/fcvm-09-996809-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a8e/9874088/c983f5dd9680/fcvm-09-996809-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a8e/9874088/478ac13862a2/fcvm-09-996809-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a8e/9874088/899d7149687b/fcvm-09-996809-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a8e/9874088/0d0df8a887cc/fcvm-09-996809-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a8e/9874088/82a8af9cb2b7/fcvm-09-996809-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a8e/9874088/811c7660d556/fcvm-09-996809-g011.jpg

相似文献

1
Identification of novel biomarkers involved in doxorubicin-induced acute and chronic cardiotoxicity, respectively, by integrated bioinformatics.通过综合生物信息学分别鉴定参与阿霉素诱导的急性和慢性心脏毒性的新型生物标志物。
Front Cardiovasc Med. 2023 Jan 11;9:996809. doi: 10.3389/fcvm.2022.996809. eCollection 2022.
2
Integrated microarray analysis to identify potential biomarkers and therapeutic targets in dilated cardiomyopathy.采用集成微阵列分析鉴定扩张型心肌病的潜在生物标志物和治疗靶点。
Mol Med Rep. 2020 Aug;22(2):915-925. doi: 10.3892/mmr.2020.11145. Epub 2020 May 14.
3
Integrative analyses of potential biomarkers and pathways for non-obstructive azoospermia.非梗阻性无精子症潜在生物标志物和通路的综合分析
Front Genet. 2022 Nov 24;13:988047. doi: 10.3389/fgene.2022.988047. eCollection 2022.
4
A Novel Hypoxia-Related Gene Signature with Strong Predicting Ability in Non-Small-Cell Lung Cancer Identified by Comprehensive Profiling.通过综合分析鉴定出一种在非小细胞肺癌中具有强大预测能力的新型缺氧相关基因特征。
Int J Genomics. 2022 May 19;2022:8594658. doi: 10.1155/2022/8594658. eCollection 2022.
5
Renal tubular gen e biomarkers identification based on immune infiltrates in focal segmental glomerulosclerosis.基于免疫浸润物的局灶节段性肾小球硬化症肾小管基因生物标志物鉴定。
Ren Fail. 2022 Dec;44(1):966-986. doi: 10.1080/0886022X.2022.2081579.
6
Bioinformatics prediction of potential mechanisms and biomarkers underlying dilated cardiomyopathy.扩张型心肌病潜在机制和生物标志物的生物信息学预测
World J Cardiol. 2022 May 26;14(5):282-296. doi: 10.4330/wjc.v14.i5.282.
7
Identification and Verification of Feature Biomarkers Associated With Immune Cells in Dilated Cardiomyopathy by Bioinformatics Analysis.通过生物信息学分析鉴定和验证扩张型心肌病中与免疫细胞相关的特征生物标志物
Front Genet. 2022 May 12;13:874544. doi: 10.3389/fgene.2022.874544. eCollection 2022.
8
Identification of hub biomarkers of myocardial infarction by single-cell sequencing, bioinformatics, and machine learning.通过单细胞测序、生物信息学和机器学习鉴定心肌梗死的核心生物标志物
Front Cardiovasc Med. 2022 Jul 25;9:939972. doi: 10.3389/fcvm.2022.939972. eCollection 2022.
9
Integrated Bioinformatics-Based Analysis of Hub Genes and the Mechanism of Immune Infiltration Associated With Acute Myocardial Infarction.基于综合生物信息学的急性心肌梗死相关枢纽基因及免疫浸润机制分析
Front Cardiovasc Med. 2022 Apr 6;9:831605. doi: 10.3389/fcvm.2022.831605. eCollection 2022.
10
Dysregulation and imbalance of innate and adaptive immunity are involved in the cardiomyopathy progression.先天性和适应性免疫的失调与失衡参与了心肌病的进展。
Front Cardiovasc Med. 2022 Sep 6;9:973279. doi: 10.3389/fcvm.2022.973279. eCollection 2022.

引用本文的文献

1
Computational approaches identify a transcriptomic fingerprint of drug-induced structural cardiotoxicity.计算方法确定了药物引起的结构性心脏毒性的转录组指纹。
Cell Biol Toxicol. 2024 Jun 28;40(1):50. doi: 10.1007/s10565-024-09880-7.
2
Liguzinediol potentiates the metabolic remodeling by activating the AMPK/SIRT3 pathway and represses Caspase-3/GSDME-mediated pyroptosis to ameliorate cardiotoxicity.利谷胱甘肽通过激活AMPK/SIRT3通路增强代谢重塑,并抑制Caspase-3/GSDME介导的细胞焦亡以改善心脏毒性。
Chin Med. 2024 Jun 14;19(1):85. doi: 10.1186/s13020-024-00955-5.

本文引用的文献

1
Cardio-Oncology: Mechanisms, Drug Combinations, and Reverse Cardio-Oncology.心脏肿瘤学:机制、药物组合与逆向心脏肿瘤学。
Int J Mol Sci. 2022 Sep 13;23(18):10617. doi: 10.3390/ijms231810617.
2
GEOexplorer: a webserver for gene expression analysis and visualisation.GEOexplorer:一个用于基因表达分析和可视化的网络服务器。
Nucleic Acids Res. 2022 Jul 5;50(W1):W367-W374. doi: 10.1093/nar/gkac364.
3
Cardio-Oncology: A Myriad of Relationships Between Cardiovascular Disease and Cancer.心脏肿瘤学:心血管疾病与癌症之间的众多关联
Front Cardiovasc Med. 2022 Mar 17;9:727487. doi: 10.3389/fcvm.2022.727487. eCollection 2022.
4
Doxorubicin induced immune abnormalities and inflammatory responses via HMGB1, HIF1-α and VEGF pathway in progressive of cardiovascular damage.阿霉素通过HMGB1、HIF1-α和VEGF途径在心血管损伤进展过程中诱导免疫异常和炎症反应。
Ann Med Surg (Lond). 2022 Mar 21;76:103501. doi: 10.1016/j.amsu.2022.103501. eCollection 2022 Apr.
5
Molecular insights into the pathophysiology of doxorubicin-induced cardiotoxicity: a graphical representation.多柔比星诱导心脏毒性的病理生理学分子研究:图形表示。
Arch Toxicol. 2022 Jun;96(6):1541-1550. doi: 10.1007/s00204-022-03262-w. Epub 2022 Mar 25.
6
Exploring the Mechanism of Danshensu in the Treatment of Doxorubicin-Induced Cardiotoxicity Based on Network Pharmacology and Experimental Evaluation.基于网络药理学和实验评价探索丹参素治疗阿霉素诱导的心脏毒性的机制
Front Cardiovasc Med. 2022 Feb 28;9:827975. doi: 10.3389/fcvm.2022.827975. eCollection 2022.
7
Cardioprotective effects of alpha-mangostin on doxorubicin-induced cardiotoxicity in rats.alpha-倒捻子素对阿霉素诱导的大鼠心脏毒性的心脏保护作用。
Phytother Res. 2022 Jan;36(1):506-524. doi: 10.1002/ptr.7356. Epub 2021 Dec 27.
8
Artificial Neural Networks Predicted the Overall Survival and Molecular Subtypes of Diffuse Large B-Cell Lymphoma Using a Pancancer Immune-Oncology Panel.人工神经网络利用泛癌免疫肿瘤学面板预测弥漫性大B细胞淋巴瘤的总生存期和分子亚型。
Cancers (Basel). 2021 Dec 20;13(24):6384. doi: 10.3390/cancers13246384.
9
Adverse Cardiovascular and Pulmonary Events Associated With Chimeric Antigen Receptor T-Cell Therapy.嵌合抗原受体 T 细胞疗法相关的心血管和肺部不良事件。
J Am Coll Cardiol. 2021 Nov 2;78(18):1800-1813. doi: 10.1016/j.jacc.2021.08.044.
10
Comparing cancer and cardiovascular disease trends in 20 middle- or high-income countries 2000-19: A pointer to national trajectories towards achieving Sustainable Development goal target 3.4.比较 2000-19 年 20 个中高收入国家的癌症和心血管疾病趋势:实现可持续发展目标 3.4 目标的国家轨迹的指向。
Cancer Treat Rev. 2021 Nov;100:102290. doi: 10.1016/j.ctrv.2021.102290. Epub 2021 Sep 9.